Atea Pharmaceuticals, Inc. Common Stock

Atea Pharmaceuticals, Inc. (AVIR) is a biotechnology company focused on developing innovative antiviral therapies for infectious diseases. The company leverages its proprietary research platform to discover and advance new treatments for viral illnesses, with an emphasis on respiratory viruses such as COVID-19. Atea collaborates with partners and clinical organizations to accelerate the development of its pipeline candidates.